Free Trial

191,331 Shares in Dolby Laboratories $DLB Bought by Martingale Asset Management L P

Dolby Laboratories logo with Consumer Discretionary background

Key Points

  • Martingale Asset Management L P has invested approximately $15.37 million in Dolby Laboratories, acquiring 191,331 shares, reflecting a stake of about 0.20% of the company.
  • Dolby Laboratories reported better-than-expected earnings with an EPS of $0.78 and revenue of $315.55 million for the last quarter, exceeding analyst expectations.
  • The company also declared a quarterly dividend of $0.33, which represents an annual yield of 1.8%, with a payout ratio of 48.35%.
  • Five stocks we like better than Dolby Laboratories.

Martingale Asset Management L P acquired a new stake in Dolby Laboratories (NYSE:DLB - Free Report) in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 191,331 shares of the electronics maker's stock, valued at approximately $15,366,000. Martingale Asset Management L P owned approximately 0.20% of Dolby Laboratories as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. Wealth Enhancement Advisory Services LLC increased its position in shares of Dolby Laboratories by 114.6% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 12,141 shares of the electronics maker's stock worth $975,000 after purchasing an additional 6,484 shares in the last quarter. Park Avenue Securities LLC acquired a new stake in shares of Dolby Laboratories during the 1st quarter worth about $222,000. Fiera Capital Corp increased its position in shares of Dolby Laboratories by 19.0% during the 1st quarter. Fiera Capital Corp now owns 639,404 shares of the electronics maker's stock worth $51,351,000 after purchasing an additional 102,028 shares in the last quarter. Vanguard Group Inc. increased its position in shares of Dolby Laboratories by 7.1% during the 1st quarter. Vanguard Group Inc. now owns 7,535,722 shares of the electronics maker's stock worth $605,194,000 after purchasing an additional 502,110 shares in the last quarter. Finally, Vise Technologies Inc. acquired a new stake in shares of Dolby Laboratories during the 4th quarter worth about $308,000. Institutional investors and hedge funds own 58.56% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on DLB. Tigress Financial increased their target price on shares of Dolby Laboratories from $112.00 to $114.00 and gave the stock a "buy" rating in a research report on Friday, August 15th. Rosenblatt Securities reiterated a "buy" rating and set a $95.00 target price on shares of Dolby Laboratories in a research report on Friday, August 1st. Barrington Research reiterated an "outperform" rating and set a $100.00 target price on shares of Dolby Laboratories in a research report on Friday, May 2nd. Finally, Wall Street Zen cut shares of Dolby Laboratories from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Three equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Dolby Laboratories presently has a consensus rating of "Buy" and an average price target of $103.00.

View Our Latest Stock Report on DLB

Dolby Laboratories Trading Down 0.5%

Shares of NYSE:DLB traded down $0.36 during trading on Tuesday, hitting $73.81. 121,580 shares of the company's stock were exchanged, compared to its average volume of 426,673. Dolby Laboratories has a 1-year low of $68.24 and a 1-year high of $89.66. The firm has a 50-day moving average price of $74.30 and a two-hundred day moving average price of $76.49. The firm has a market cap of $7.07 billion, a P/E ratio of 27.04 and a beta of 0.91.

Dolby Laboratories (NYSE:DLB - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The electronics maker reported $0.78 EPS for the quarter, topping the consensus estimate of $0.72 by $0.06. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The company had revenue of $315.55 million during the quarter, compared to analysts' expectations of $305.23 million. During the same quarter in the previous year, the company earned $0.71 EPS. Dolby Laboratories's revenue was up 9.2% on a year-over-year basis. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. As a group, research analysts predict that Dolby Laboratories will post 2.94 EPS for the current year.

Dolby Laboratories Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, August 20th. Stockholders of record on Tuesday, August 12th were given a dividend of $0.33 per share. The ex-dividend date was Tuesday, August 12th. This represents a $1.32 annualized dividend and a dividend yield of 1.8%. Dolby Laboratories's payout ratio is currently 48.35%.

Insider Activity at Dolby Laboratories

In other news, CEO Kevin J. Yeaman sold 25,000 shares of Dolby Laboratories stock in a transaction that occurred on Tuesday, August 12th. The shares were sold at an average price of $72.31, for a total transaction of $1,807,750.00. Following the completion of the sale, the chief executive officer owned 114,725 shares in the company, valued at $8,295,764.75. The trade was a 17.89% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Mark Andrew Sherman sold 15,000 shares of the business's stock in a transaction that occurred on Wednesday, June 4th. The shares were sold at an average price of $75.02, for a total transaction of $1,125,300.00. Following the transaction, the executive vice president owned 62,397 shares of the company's stock, valued at approximately $4,681,022.94. This represents a 19.38% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 141,049 shares of company stock valued at $10,521,141. 38.39% of the stock is owned by corporate insiders.

Dolby Laboratories Profile

(Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Featured Stories

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Should You Invest $1,000 in Dolby Laboratories Right Now?

Before you consider Dolby Laboratories, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.

While Dolby Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.